Ajanta Pharma, specializing in specialty pharmaceutical manufacturing and marketing, reported a solid Q2 FY26 performance. Financial Overview: Revenues increased 14.07% to ₹1,354
(AJANTPHARM)
Ajanta Pharma Ltd Q1 FY26 Earnings Results – Revenue Up 13.8%, Net Profit Up 3.7% YoY
Ajanta Pharma Limited is a specialty pharmaceutical company primarily engaged in the development, manufacturing, and marketing of high-quality finished dosage formulations. The
Ajanta Pharma Ltd Q4FY25; 11% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Ajanta Pharma Ltd Q3FY25; 11% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Ajanta Pharma Ltd Q2FY25; 11% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).